atractylenolide iii has been researched along with Silicosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Kang, H; Tan, S; Wang, H; Yang, S; Zhang, Y; Zhou, K | 1 |
| Chen, G; Chen, S; Hu, P; Luo, Y; Tan, S; Tang, K; Yang, C; Yang, S; Zou, H | 1 |
2 other study(ies) available for atractylenolide iii and Silicosis
| Article | Year |
|---|---|
Atractylenolide III Ameliorated Autophagy Dysfunction via Epidermal Growth Factor Receptor-Mammalian Target of Rapamycin Signals and Alleviated Silicosis Fibrosis in Mice.
Topics: Animals; Autophagy; ErbB Receptors; Fibrosis; Humans; Mice; Silicosis; Sirolimus; TOR Serine-Threonine Kinases | 2023 |
Atractylenolide III alleviates the apoptosis through inhibition of autophagy by the mTOR-dependent pathway in alveolar macrophages of human silicosis.
Topics: Apoptosis; Autophagy; Bronchoalveolar Lavage Fluid; Cells, Cultured; Cholinergic Antagonists; Humans; Lactones; Macrophages, Alveolar; Sesquiterpenes; Silicosis; TOR Serine-Threonine Kinases | 2021 |